Willow Biosciences CANSF Stock
0.005 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
United States
Exchange
OTC Markets OTCQB
Market Cap
1.04M USD
LOW - HIGH [24H]
0.0061
-
0.0071 USD
VOLUME [24H]
40K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.04 USD
Willow Biosciences Price Chart
Willow Biosciences CANSF Financial and Trading Overview
| Willow Biosciences stock price | 0.0050 USD |
| Previous Close | 0.09 USD |
| Open | 0.09 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.09 - 0.1 USD |
| 52 Week Range | 0.06 - 0.14 USD |
| Volume | 80.62K USD |
| Avg. Volume | 24.47K USD |
| Market Cap | 12.11M USD |
| Beta (5Y Monthly) | 1.100545 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2 USD |
CANSF Valuation Measures
| Enterprise Value | 1.13M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 11.0621805 |
| Price/Book (mrq) | 0.96842104 |
| Enterprise Value/Revenue | 1.028 |
| Enterprise Value/EBITDA | -0.066 |
Trading Information
Willow Biosciences Stock Price History
| Beta (5Y Monthly) | 1.100545 |
| 52-Week Change | -33.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.14 USD |
| 52 Week Low | 0.06 USD |
| 50-Day Moving Average | 0.09 USD |
| 200-Day Moving Average | 0.09 USD |
CANSF Share Statistics
| Avg. Volume (3 month) | 24.47K USD |
| Avg. Daily Volume (10-Days) | 31.59K USD |
| Shares Outstanding | 124.22M |
| Float | 88.45M |
| Short Ratio | N/A |
| % Held by Insiders | 27.89% |
| % Held by Institutions | 0.12% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1680.36% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -52.47% |
| Return on Equity (ttm) | -85.26% |
Income Statement
| Revenue (ttm) | 1.1M USD |
| Revenue Per Share (ttm) | 0.009 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 821K USD |
| EBITDA | -16968000 USD |
| Net Income Avi to Common (ttm) | -16615000 USD |
| Diluted EPS (ttm) | -0.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.81M USD |
| Total Cash Per Share (mrq) | 0.09 USD |
| Total Debt (mrq) | 507K USD |
| Total Debt/Equity (mrq) | 4.31 USD |
| Current Ratio (mrq) | 6.708 |
| Book Value Per Share (mrq) | 0.095 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14624000 USD |
| Levered Free Cash Flow (ttm) | -8404250 USD |
Profile of Willow Biosciences
| Country | United States |
| State | AB |
| City | Calgary |
| Address | 202, 1201-5th Street SW |
| ZIP | T2R 0Y6 |
| Phone | 403 910 5140 |
| Website | https://www.willowbio.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 32 |
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. Willow Biosciences Inc. is headquartered in Calgary, Canada.
Q&A For Willow Biosciences Stock
What is a current CANSF stock price?
Willow Biosciences CANSF stock price today per share is 0.0050 USD.
How to purchase Willow Biosciences stock?
You can buy CANSF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Willow Biosciences?
The stock symbol or ticker of Willow Biosciences is CANSF.
Which industry does the Willow Biosciences company belong to?
The Willow Biosciences industry is Drug Manufacturers-Specialty & Generic.
How many shares does Willow Biosciences have in circulation?
The max supply of Willow Biosciences shares is 208.95M.
What is Willow Biosciences Price to Earnings Ratio (PE Ratio)?
Willow Biosciences PE Ratio is now.
What was Willow Biosciences earnings per share over the trailing 12 months (TTM)?
Willow Biosciences EPS is -0.04 USD over the trailing 12 months.
Which sector does the Willow Biosciences company belong to?
The Willow Biosciences sector is Healthcare.